A contemporary update on pathology reporting for prostate cancer

Biopsy and radical prostatectomy specimens

Samson W. Fine, Mahul Amin, Daniel M. Berney, Anders Bjartell, Lars Egevad, Jonathan I. Epstein, Peter A. Humphrey, Christina Magi-Galluzzi, Rodolfo Montironi, Christian Stief

Research output: Contribution to journalReview article

67 Citations (Scopus)

Abstract

Context: The diagnosis of and reporting parameters for prostate cancer (PCa) have evolved over time, yet they remain key components in predicting clinical outcomes. Objective: Update pathology reporting standards for PCa. Evidence acquisition: A thorough literature review was performed for articles discussing PCa handling, grading, staging, and reporting published as of September 15, 2011. Electronic articles published ahead of print were also considered. Proceedings of recent international conferences addressing these areas were extensively reviewed. Evidence synthesis: Two main areas of reporting were examined: (1) prostatic needle biopsy, including handling, contemporary Gleason grading, extent of involvement, and high-risk lesions/precursors and (2) radical prostatectomy (RP), including sectioning, multifocality, Gleason grading, staging of organ-confined and extraprostatic disease, lymph node involvement, tumor volume, and lymphovascular invasion. For each category, consensus views, controversial areas, and clinical import were reviewed. Conclusions: Modern prostate needle biopsy and RP reports are extremely detailed so as to maximize clinical utility. Accurate diagnosis of cancer-specific features requires up-to-date knowledge of grading, quantitation, and staging criteria. While some areas remain controversial, efforts to codify existing knowledge have had a significant impact on pathology practice.

Original languageEnglish (US)
Pages (from-to)20-39
Number of pages20
JournalEuropean Urology
Volume62
Issue number1
DOIs
StatePublished - Jul 1 2012
Externally publishedYes

Fingerprint

Prostatectomy
Prostatic Neoplasms
Neoplasm Grading
Needle Biopsy
Pathology
Biopsy
Tumor Burden
Prostate
Lymph Nodes
Neoplasms

All Science Journal Classification (ASJC) codes

  • Urology

Cite this

A contemporary update on pathology reporting for prostate cancer : Biopsy and radical prostatectomy specimens. / Fine, Samson W.; Amin, Mahul; Berney, Daniel M.; Bjartell, Anders; Egevad, Lars; Epstein, Jonathan I.; Humphrey, Peter A.; Magi-Galluzzi, Christina; Montironi, Rodolfo; Stief, Christian.

In: European Urology, Vol. 62, No. 1, 01.07.2012, p. 20-39.

Research output: Contribution to journalReview article

Fine, SW, Amin, M, Berney, DM, Bjartell, A, Egevad, L, Epstein, JI, Humphrey, PA, Magi-Galluzzi, C, Montironi, R & Stief, C 2012, 'A contemporary update on pathology reporting for prostate cancer: Biopsy and radical prostatectomy specimens', European Urology, vol. 62, no. 1, pp. 20-39. https://doi.org/10.1016/j.eururo.2012.02.055
Fine, Samson W. ; Amin, Mahul ; Berney, Daniel M. ; Bjartell, Anders ; Egevad, Lars ; Epstein, Jonathan I. ; Humphrey, Peter A. ; Magi-Galluzzi, Christina ; Montironi, Rodolfo ; Stief, Christian. / A contemporary update on pathology reporting for prostate cancer : Biopsy and radical prostatectomy specimens. In: European Urology. 2012 ; Vol. 62, No. 1. pp. 20-39.
@article{94654bd8e99a45df80eafb46fcb8343e,
title = "A contemporary update on pathology reporting for prostate cancer: Biopsy and radical prostatectomy specimens",
abstract = "Context: The diagnosis of and reporting parameters for prostate cancer (PCa) have evolved over time, yet they remain key components in predicting clinical outcomes. Objective: Update pathology reporting standards for PCa. Evidence acquisition: A thorough literature review was performed for articles discussing PCa handling, grading, staging, and reporting published as of September 15, 2011. Electronic articles published ahead of print were also considered. Proceedings of recent international conferences addressing these areas were extensively reviewed. Evidence synthesis: Two main areas of reporting were examined: (1) prostatic needle biopsy, including handling, contemporary Gleason grading, extent of involvement, and high-risk lesions/precursors and (2) radical prostatectomy (RP), including sectioning, multifocality, Gleason grading, staging of organ-confined and extraprostatic disease, lymph node involvement, tumor volume, and lymphovascular invasion. For each category, consensus views, controversial areas, and clinical import were reviewed. Conclusions: Modern prostate needle biopsy and RP reports are extremely detailed so as to maximize clinical utility. Accurate diagnosis of cancer-specific features requires up-to-date knowledge of grading, quantitation, and staging criteria. While some areas remain controversial, efforts to codify existing knowledge have had a significant impact on pathology practice.",
author = "Fine, {Samson W.} and Mahul Amin and Berney, {Daniel M.} and Anders Bjartell and Lars Egevad and Epstein, {Jonathan I.} and Humphrey, {Peter A.} and Christina Magi-Galluzzi and Rodolfo Montironi and Christian Stief",
year = "2012",
month = "7",
day = "1",
doi = "10.1016/j.eururo.2012.02.055",
language = "English (US)",
volume = "62",
pages = "20--39",
journal = "European Urology",
issn = "0302-2838",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - A contemporary update on pathology reporting for prostate cancer

T2 - Biopsy and radical prostatectomy specimens

AU - Fine, Samson W.

AU - Amin, Mahul

AU - Berney, Daniel M.

AU - Bjartell, Anders

AU - Egevad, Lars

AU - Epstein, Jonathan I.

AU - Humphrey, Peter A.

AU - Magi-Galluzzi, Christina

AU - Montironi, Rodolfo

AU - Stief, Christian

PY - 2012/7/1

Y1 - 2012/7/1

N2 - Context: The diagnosis of and reporting parameters for prostate cancer (PCa) have evolved over time, yet they remain key components in predicting clinical outcomes. Objective: Update pathology reporting standards for PCa. Evidence acquisition: A thorough literature review was performed for articles discussing PCa handling, grading, staging, and reporting published as of September 15, 2011. Electronic articles published ahead of print were also considered. Proceedings of recent international conferences addressing these areas were extensively reviewed. Evidence synthesis: Two main areas of reporting were examined: (1) prostatic needle biopsy, including handling, contemporary Gleason grading, extent of involvement, and high-risk lesions/precursors and (2) radical prostatectomy (RP), including sectioning, multifocality, Gleason grading, staging of organ-confined and extraprostatic disease, lymph node involvement, tumor volume, and lymphovascular invasion. For each category, consensus views, controversial areas, and clinical import were reviewed. Conclusions: Modern prostate needle biopsy and RP reports are extremely detailed so as to maximize clinical utility. Accurate diagnosis of cancer-specific features requires up-to-date knowledge of grading, quantitation, and staging criteria. While some areas remain controversial, efforts to codify existing knowledge have had a significant impact on pathology practice.

AB - Context: The diagnosis of and reporting parameters for prostate cancer (PCa) have evolved over time, yet they remain key components in predicting clinical outcomes. Objective: Update pathology reporting standards for PCa. Evidence acquisition: A thorough literature review was performed for articles discussing PCa handling, grading, staging, and reporting published as of September 15, 2011. Electronic articles published ahead of print were also considered. Proceedings of recent international conferences addressing these areas were extensively reviewed. Evidence synthesis: Two main areas of reporting were examined: (1) prostatic needle biopsy, including handling, contemporary Gleason grading, extent of involvement, and high-risk lesions/precursors and (2) radical prostatectomy (RP), including sectioning, multifocality, Gleason grading, staging of organ-confined and extraprostatic disease, lymph node involvement, tumor volume, and lymphovascular invasion. For each category, consensus views, controversial areas, and clinical import were reviewed. Conclusions: Modern prostate needle biopsy and RP reports are extremely detailed so as to maximize clinical utility. Accurate diagnosis of cancer-specific features requires up-to-date knowledge of grading, quantitation, and staging criteria. While some areas remain controversial, efforts to codify existing knowledge have had a significant impact on pathology practice.

UR - http://www.scopus.com/inward/record.url?scp=84861599138&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84861599138&partnerID=8YFLogxK

U2 - 10.1016/j.eururo.2012.02.055

DO - 10.1016/j.eururo.2012.02.055

M3 - Review article

VL - 62

SP - 20

EP - 39

JO - European Urology

JF - European Urology

SN - 0302-2838

IS - 1

ER -